Kailera Therapeutics, Inc. (NASDAQ:KLRA) Stock Has Average Target Price of $42.75
MarketBeat
Shares of Kailera Therapeutics, Inc. (NASDAQ:KLRA - Get Free Report) have earned an average rating of "Moderate Buy" from the eight ratings firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating, five
NASDAQ:KLRA